If you thought our angle on this company was interesting, you may want to check out our idea room, The Value Lab . We focus on long-only value ideas of interest to us, where we try to find international mispriced equities and target a portfolio yield of about 4% . We've done really well for ourselves over the last 5 years, but it took getting our hands dirty in international markets. If you are a value-investor, serious about protecting your wealth, our gang could help broaden your horizons and give some in ...

What: HCA Healthcare, Inc. 4Q 2025 Earnings Call When: Tuesday, January 27, 2026 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx ...

Philadelphia, Pennsylvania--(Newsfile Corp. - December 30, 2025) - Grabar Law Office is investigating claims on behalf of shareholders of Lifecore Biomedical, Inc. (NASDAQ: LFCR) The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.Current Lifecore Biomedical, Inc. (NASDAQ: LFCR) who have held shares since before October 7, 2020 can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no ...

Apple ( AAPL ) is one of the few U.S. big tech stocks that has not performed well in 2025. Up 8.5% for the year, it has lagged behind the S&P 500 by a considerable margin.Analyst’s Disclosure:I/we have a beneficial long position in the shares of GOOGL, GOOG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose s ...

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Baidu, Inc. (“Baidu” or the “Company”) (NASDAQ: BIDU).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Baidu and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On November 26, 2025, B ...

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Waldencast plc (“Waldencast” or the “Company”) (NASDAQ: WALD).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.    The investigation concerns whether Waldencast and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Nove ...

Shares opened mixed in Europe on Tuesday after slipping in Asia as some regional markets wrapped up trading for the year. Crude oil prices edged higher and gold and silver resumed their ascent. U.S. futures were flat. In Tokyo, Japanese Prime Minister Sanae Takaichi rang out the final session for 2025 in a traditional year-end ceremony. "By realizing a Japanese economy that earns the trust of investors around the world, we will create a virtuous cycle in which global capital flows into Japan,†Takaichi said. ...

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Ventyx Biosciences, Inc. (“Ventyx” or the “Company”) (NASDAQ: VTYX).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ventyx and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On Decem ...

文章作者与发布平台 - 文章作者Terry Chrisomalis是生物科技领域的私人投资者 拥有多年应用科学背景 专注于医疗保健领域的长期价值投资 [2] - 作者运营名为Biotech Analysis Central的投资研究服务 该服务发布在Seeking Alpha Marketplace平台上 [1] - 该服务提供对多家制药公司的深度分析 其月度订阅费为49美元 年度订阅计划享有33.50%的折扣 年费为399美元 [1] - 作者是Biotech Analysis Central投资研究小组的发起人 该小组拥有超过600篇生物科技投资文章库 一个包含10多只中小盘股票的投资组合模型 并提供实时聊天及各类分析新闻报道 [2] 文章背景与关联内容 - 作者此前曾撰写关于Verastem, Inc. (VSTM)的文章 标题为“Verastem: RAMP-203研究可能成为Avutometinib组合疗法的下一个重大胜利” [2] - 当前文章是对前述Verastem相关分析的延续或进一步探讨 [2]

诉讼事件概述 - 一家领先的国际证券律师事务所Bleichmar Fonti & Auld LLP宣布，已对Alexandria Real Estate Equities, Inc及其部分高级管理人员提起集体诉讼，指控其证券欺诈[1] - 该诉讼源于公司股价因可能违反联邦证券法而出现大幅下跌[1] - 诉讼依据《1934年证券交易法》第10(b)和20(a)条提出，代表Alexandria Real Estate证券的投资者提起，案件正在美国加利福尼亚中区地方法院审理[3] 公司业务与指控背景 - Alexandria Real Estate是一家房地产投资信托基金，其租户主要集中在生命科学行业，如制药和生物技术公司[4] - 在相关期间，公司曾宣扬其租赁量和开发管道，特别提及纽约长岛市的一处房产，称租赁量“稳固”，其管道“定位良好，可在扩张需求出现时捕捉未来需求”[5] - 据指控，事实上公司正经历较低的入住率和较慢的租赁活动，以至于需要计提3.239亿美元的房地产减值损失，其中2.06亿美元归因于其长岛市房产[5] 股价下跌直接原因 - 2025年10月27日，公司宣布2025年第三季度业绩不及预期，并下调了本财年剩余时间的业绩指引[6] - 公司将业绩归因于较低的入住率和较慢的租赁活动，并宣布了3.239亿美元的房地产减值损失，其中2.06亿美元归因于长岛市房产，称该房产并非一个可扩展的生命科学目的地[6] - 公司还宣布可能在2025年第四季度确认额外的减值损失，范围在0至6.85亿美元之间[6] - 此消息导致公司股价从2025年10月27日的收盘价每股77.87美元下跌14.93美元，至2025年10月28日的每股62.94美元，跌幅超过19%[6] 律师事务所信息 - 代理此案的Bleichmar Fonti & Auld LLP是一家代表原告处理证券集体诉讼和股东诉讼的领先国际律师事务所[8] - 该律所曾被Chambers USA、The Legal 500和ISS SCAS评为顶级原告律师事务所，其律师曾获得多项荣誉[8] - 该律所近期的显著成功案例包括从特斯拉公司董事会追回超过9亿美元的价值，以及从Teva Pharmaceutical Ind. Ltd追回4.2亿美元[8]